KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Inventory (2018 - 2025)

Historic Inventory for Rigel Pharmaceuticals (RIGL) over the last 8 years, with Q3 2025 value amounting to $13.3 million.

  • Rigel Pharmaceuticals' Inventory rose 17807.27% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 17807.27%. This contributed to the annual value of $6.0 million for FY2024, which is 869.25% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Inventory stood at $13.3 million for Q3 2025, which was up 17807.27% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Inventory ranged from a high of $13.3 million in Q3 2025 and a low of $4.7 million during Q1 2025
  • Over the past 5 years, Rigel Pharmaceuticals' median Inventory value was $6.8 million (recorded in 2021), while the average stood at $7.6 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Inventory soared by 32829.84% in 2021 and then plummeted by 4060.67% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Inventory (Quarter) stood at $6.6 million in 2021, then surged by 37.82% to $9.1 million in 2022, then plummeted by 39.44% to $5.5 million in 2023, then grew by 8.69% to $6.0 million in 2024, then skyrocketed by 121.64% to $13.3 million in 2025.
  • Its Inventory stands at $13.3 million for Q3 2025, versus $10.4 million for Q2 2025 and $4.7 million for Q1 2025.